semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 30.0-65.0,  Cardiovascular Disease Risk Factors Men and women 30-65 years of age 2. BMI ≥ 18 and ≤ 39 kg/m^2 3. Total cholesterol below 273 mg/dL for men and below 284 mg/dL for women 4. Triglycerides below 350 mg/dL 5. Non-smokers 6. At least one of the following: 1. Systolic blood pressure 120-159 mmHg 2. Diastolic blood pressure 80-99 mmHg  History of acute or chronic inflammatory conditions or heart disease, kidney disease, liver disease, autoimmune disorders, or thyroid disease (unless controlled by medication and blood results within previous 6 months are provided) 2. History of diabetes mellitus (and/or a fasting glucose >126 mg/dL at screening) 3. Stage II hypertension (blood pressure ≥ 160/100 mmHg) 4. Lactation, pregnancy, or desire to become pregnant during the study 5. Unwillingness to discontinue nutritional supplements, herbs, or vitamins unless approved by investigator 6. Use of medications/supplements for elevated lipids, blood pressure, or glucose 7. Chronic use of non-steroidal anti-inflammatory or immunosuppressant medication 8. Conditions requiring the use of steroids 9. Unwillingness to refrain from blood donation prior to and during the study 10. Any medical condition or abnormal laboratory value that is judged clinically significant by an investigator 11. Allergy or sensitivity to cranberry juice or any ingredient in the study beverages
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 35.0-75.0,  Sleep Apnea Dyslipidaemia Diagnosis of dyslipidemia: The existence of a previous clinical diagnostic of dyslipidemia associated with lipid-lowering therapy. It is also considered patients who have an altered analytical, using the following cutoffs: total cholesterol ≥ 200 mg / dl, triglycerides ≥ 180 mg / dl, HDL-cholesterol ≤ 40 mg / dl or LDL-cholesterol ≥ 150 mg / dl. Lipid-lowering treatment and diet, stable in the last month A concentration of LDL-cholesterol above 100 mg / dl, in the month prior to inclusion An apnea-hypopnea index between 5-30 h-1  Apnea-hypopnea index of less than 5 h-1 or greater than 30 h-1 Predominance of central apneas and hypopneas, defined as more than 25% of all respiratory events Professional drivers, risk profession or respiratory failure (according to of the clinical pathway for diagnosis and treatment of sleep-disordered breathing) Very excessive daytime sleepiness (Epworth Sleepiness Scale> 18) Morbid obesity (BMI> 40 kg / m2) Prior treatment with CPAP
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-70.0,  Weight Loss Obesity Diabetes Diet, Reducing Carbohydrates Protein Age: 18-70 years old Body mass index between 27.5 Steady weight (± 4 kg) in the last 2 months Glycated hemoglobin between 6  Anti-diabetic drugs (oral or subcutaneous) in the last 2 months Lipid-lowering drugs in the last 2 months Gouty arthritis in the last 2 years or uric acid > 735 mg/dl Presence of uncontrolled endocrinological pathology (including hypothyroidism) Hepatic chronic disease (glomerular filtration rate < 45 ml/min) Renal, inflammatory or tumoral diseases Drugs which could interfere in glucose or lipid metabolism such as androgens, corticosteroids (except for those with topic administration) and estrogen replacement therapy Intake of functional foods with plant sterols in the past 6 weeks High alcohol intake (> 30 g per day) Any serious disease which involves less than 1 year life expectancy or, in investigators judgment, limit the follow-up of an homogeneous diet throughout the study
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 20.0-40.0,  Postpartum Hemorrhage Women who accept to participate (either the patient or her first-kin if she is unconscious) 2. Primary atonic postpartum hemorrhage  Traumatic postpartum haemorrhage
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 20.0-50.0,  Urinary Albumin Excretion PCO patients  pregnancy diabetes hypertension adrenal dysfunction thyroid dysfunction
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-85.0,  Hyperlipidemia Either gender, in general good health, between 25-85 years old 2. Serum TG 150-495 mg/dl at screening 3. Serum LDL >/= 70 mg/dl at screening 4. Not using any other product including drugs, medical foods, neutraceuticals or dietary supplements for control of serum lipids 5. Consistent dietary habits 6. Women of child bearing potential must use an accepted method of birth control 7. Able to read and understand study documents including the Subject Informed Consent Document (Spanish language translation available, if needed)  serum TG <150 or >495 mg/dl at screening visit 2. serum LDL<50 mg/dl at screening visit 3. use of any other serum lipid modifying agent (see section 6.0) within 4 weeks of screening visit 4. history of any intestinal disease that might interfere with absorption 5. history of pancreatitis, inflammatory colitis or prior cholecystectomy 6. any active malignancy or history of malignancy, except basal cell carcinoma or cervical carcinoma in situ curatively treated, within 3 years of the screening visit 7. screening AST, ALT, alkaline phosphatase, bilirubin >1.3 times the upper limit of normal for the reference laboratory 8. serum creatinine >2.0 9. uncontrolled diabetes mellitus (glycosylated Hgb >9) 10. diabetes mellitus not on stable therapy for at least 2 months 11. uncontrolled hypertension (DBP >100, SPB >160) 12. unstable angina, congestive heart failure or other uncontrolled cardiac disease 13. pregnant or lactating women 14. known history of allergies to O-3 fatty acids, carotenoids, vitamin E or fish products 15. history of substance abuse or any psychiatric condition that may impair the subject's ability to comply with the study requirements. 16. Regular consumption of more than one (1) unit of alcohol daily. For the purposes of this study a unit of alcohol consists of 12 oz. of beer, 6 oz. of wine or 2 oz of hard spirits. 17. any medical condition that, in the opinion of the investigator, might put the subject at undue risk or might interfere with the subject's ability to participate in the study 18. participation in another clinical trial within 30 days or 6 half lives of the study agent, whichever is longer, of the screening visit
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 12.0-17.0,  Pediatric Obesity Sleep Apnea, Obstructive Obese adolescents (BMI > 97th percentile) patients aged from 12 to 17 years old, (born between 07/01/2003 and 09/01/1197) enrolled in a pediatric obesity center with diet and physical activity programs and psychological management without observed tonsils hypertrophy (Mallampati and Friedman scores) without contraindication for bioimpedance analysis, acoustic method and stain gauge plethysmography with physical activity certificate issued by a cardiologist covered by the national insurance scheme of his/her legal representative having signed, as well as his(her) legal representative, the informed consent of participation  Non obese adolescents (BMI < 97th percentile) patients aged under 12 or over 17 years old not enrolled in a pediatric obesity center with diet and physical activity programs and psychological management with observed tonsils hypertrophy (Mallampati and Friedman scores) with contraindication for bioimpedance analysis, acoustic method and stain gauge plethysmography without physical activity certificate issued by a cardiologist uncovered by the national insurance scheme of his/her legal representative not having signed, as well as his(her) legal representative, the informed consent of participation
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Insulin Resistance Participants with BMI >/=30 kg/m^2 and </=40 kg/m^2 or BMI >27 kg/m^2 and <30 kg/m^2 and Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) >3.60 or waist circumference >100 centimeters (cm) (males) or 88 cm (females) or fasting plasma insulin >/=15 milli international unit per liter (mIU/L) or fasting plasma glucose >/=100 milligrams per deciliter (mg/dL) and <126 mg/dL or hemoglobin A1c (HbA1c) >5.6 percent (%) and <6.5% Negative pregnancy test  A diagnosis of Type 2 diabetes mellitus at any time Pregnant, lactating or intending to become pregnant during the study or within 3 months after the study dose is administered Uncontrolled intercurrent illness or any psychiatric illness Participants actively involved in a weight loss or dietary program within the last 6 months History of surgical procedures for weight loss History of eating disorder Uncontrolled hypertension (systolic >/=140 millimeter of mercury [mmHg] or diastolic blood pressure >/=90 mmHg) either on or off therapy at screening or Day -2 Fasting triglycerides >500 mg/dL (5.64 millimoles per liter [mmol/L]) or low density lipoprotein (LDL) >160 mg/dL (4.14 mmol/L) at screening Any serious medical condition or abnormality in clinical laboratory tests
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 22.0-75.0,  Obesity Osteoarthritis Age 22-75 years Subject is diagnosed with Non-inflammatory Degenerative Joint Disease(NIDJD) Subject is diagnosed with Morbid Obesity (Body Mass Index ≥ 40 kg/m2 or >35 kg/m2 with qualifying comorbid conditions such as obstructive sleep apnea or diabetes) Subject is a suitable candidate for cemented primary TKA with either resurfaced or non-resurfaced patellae Subject is currently not bedridden Subject, in the opinion of the Clinical Investigator, is able to understand this clinical investigation and co-operate with investigational procedures Subject has given voluntary, written informed consent to participate in this clinical investigation Subject is comfortable with speaking, reading, and understanding questions and providing responses in an available translated language  Subject has undergone THA or contralateral knee within the past 6 months Subject has had a contralateral amputation Subject requires simultaneous bilateral TKA Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement), patellectomy, high tibial osteotomy or primary TKA in affected knee Subject is currently experiencing radicular pain from the spine Subject was diagnosed with fibromyalgia that is currently being treated with prescription medication Subject has significant neurological or musculoskeletal disorders or disease that may adversely affect gait or weight bearing (e.g. muscular dystrophy, multiple sclerosis, Charcot disease) Subject is suffering from inflammatory arthritis (e.g. rheumatoid arthritis, juvenile rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, etc.) Subject has had previous bariatric surgery Subject is medically or psychologically not suitable to undergo surgery
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 60.0-999.0,  Sleep years old or more healthy men  Basal Apnea-Hypopnea index (aHI)>=15 Restless Legs Syndrome Symptons BMI less than 18.5 kg/m2 or greater than 30 kg/m2 Less than 30 min. of regular physical activity (at least walking inside home, etc.) Plasma albumin below 3.5 mg/dL Psychoactive drugs use Drugs with muscle anabolic potential Current treatment for obesity or weight gain Enteral or parenteral feeding Inability to walk without assistance
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 19.0-35.0,  Polycystic Ovary Syndrome Women aged between 19 and 35 years Diagnosis of PCOS according to the modified Rotterdam criteria years after menarche Body mass index (BMI) equal to or greater than 23 kg/m*m  Administration of other medications known to affect reproductive function or metabolism within the past three months, including oral contraceptives, Gonadotropin-releasing hormone (GnRH) agonists and antagonists, anti androgens, gonadotropins, anti-obesity drugs, Chinese herbal medicines, anti diabetic drugs such as metformin and thiazolidinediones, somatostatin, diazoxide, and calcium channel blockers Patients with other endocrine disorder including 21-hydroxylase deficiency, hyperprolactinemia, uncorrected thyroid disease, suspected Cushing's syndrome Patients with known severe organ dysfunction or mental illness
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 0.25-18.0,  Hypertension, Pulmonary Patient must be an incident patient, i.e.newly diagnosed with PH Age at time of diagnosis is at least 3 months and less than 18 years Patients must present with PH belonging to one of the following categories Group 1 according to updated Nice clinical classification Group 3 according to updated Nice clinical classification Group 4 according to updated Nice clinical classification Group 5 according to updated Nice clinical classification PH confirmed by heart catheterisation (HC) At HC, the patient must present with mean pulmonary arterial pressure (PAP) of at least 25 mmHg at rest, a pulmonary vascular resistance index (PVRi) equal to or below 3 Wood units*m^2 and mean pulmonary arterial wedge pressure (PAWP) below or equal to 15 mmHg In case of congenital heart disease (CHD) patients who had undergone palliative procedure or repair to close systemic to pulmonary shunt, the diagnosis of PH must have been confirmed by HC at least 6 months after surgery/palliative procedure took place  Patients belonging to Group 2 according to updated Nice clinical classification
Patient description: The patient is a 32-year-old obese woman who came to the clinic with weight concerns. She is 165 cm tall and her weight is 113 kg. She is complaining of sleep apnea, PCO and dissatisfaction with her body shape. She is a high-school teacher married for 5 years. She doesn't use any contraceptive methods for the past 4 months and she had no prior pregnancies. She doesn't smoke or use any drugs. She likes to try diets and exercise to lose weight. She completed the four square step test in 14 seconds. Her BP: 130/80, HR: 195/min and her BMI is: 41.54. Her labs: FBS: 98 mg/dl TG: 150 mg/dl Cholesterol: 180 mg/dl LDL: 90 mg/dl HDL: 35 mg/dl Her cardiac assessment is normal. Her joints and ROM are within normal.

Clinical trial eligibility criteria: eligible ages (years): 30.0-40.0,  Obesity Gender: male and female Age: 30-40 years Diagnosis of obesity and normal weight according to WHO: Individuals with normal weight or BMI ≥ 18.5 to 24.9 kg / m2. Individuals with obesity or BMI ≥ 30 to 39.9 kg / m2. • Diagnosis absence of visceral obesity according to WHO: Normal Weight; waist circumference: Women <80 cm and men <90 cm. • Diagnosis of visceral obesity according to WHO: waist circumference: Women and men ≥ 80 cm ≥ 90 cm What are sedentary during the past three months. Individuals committed in 15-30 minutes of physical activity exclusively by at least 3 times a week at most No change in the oral glucose tolerance according to the ADA: or fasting glucose <100 mg / dL and afterload glucose <140 mg / dL. • written informed consent  Women pregnant or lactating Diagnosis of DM according to the ADA. Fasting glucose: ≥ 126 mg / dL glucose and afterload: ≥ 140 mg / dL Thyroid disease and / or hypertension Diagnosis of metabolic syndrome Consumption of oral agents or other medicines and supplements with proven properties that modify the behavior of glucose Liver enzymes: GOT and GPT concentrations twice normal Changes in GFR according to the Cockcroft and Gault, with levels below 60 mL / min / 1.73 m2, which is suggestive of chronic kidney disease Changes in serum lipid levels: Total cholesterol <200 mg / dL Triglycerides <150 mg / dL HDL-C > 60 mg / dL or LDL-C <130 mg / dL